CD28 antibody
Quick Overview for CD28 antibody (ABIN6961445)
Target
See all CD28 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Human
-
Purification
- This monoclonal antibody preparation was purified from tissue culture supernatant via affinity chromatography. For In Vivo Ready™ (IVR) products, each preparation is also evaluated for endotoxin levels using the LAL assay. It is recommended to store the product undiluted at 4°C. Do not freeze.
-
Endotoxin Level
- Low endotoxin: < 0.01 EU/ug
-
Isotype
- IgG2a kappa
-
-
-
-
Application Notes
- This purified format is guaranteed to be >90 % pure as determined by SDS-PAGE analysis.
-
Comment
-
2 mg/mL
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 10 mM NaH2PO4, 150 mM NaCl, pH 7.2
-
Preservative
- Azide free
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C
-
Expiry Date
- 12 months
-
-
- CD28
-
Alternative Name
- CD28
-
Background
- The CD28.6 antibody reacts with human CD28, a 44 kDa type I surface glycoprotein which acts as a co-stimulatory receptor in support of the T cell receptor (TCR). CD28 exists as a homodimer with specificity for two known ligands, known as B7-1 (CD80) and B7-2 (CD86), which are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activation to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between the B7 ligands and CD28 provides crucial communication between T cells and B cells or APCs to coordinate the adaptive immune response. The CD28.6 antibody is reported to have neutralizing activity and is also useful for western blotting.
-
Gene ID
- 940
-
UniProt
- P10747
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-